Together, these results suggest that tau can act in concert with amyloid-beta (as shown in AD; Skillbäck et al., 2015) and alpha-synuclein (as in some cases of Parkinson’s disease; Goris et al., 2007 and Moussaud et al., 2014). This evidence concerns the gene MAPT and Alzheimer disease.